baber/WOPTO huggingface dataset:
Patent FI-961036-A0 (FI)
Inventor: SACCHETTI MARIO
IPC: C08F10/00
Filed: 1996-03-06
Abstract: Components of bimetallic catalysts for the polymerization of olefins comprising a compound of a transition metal M selected from Ti, V, Zr and Hf containing at least one M-pibond, a compound of Ti or V not containing metal-pi bonds and a support comprising a magnesium halide. The catalysts obtained from the components of the invention are particularly suitable for gas-phase polymerization processes.
Patent FI-963598-A0 (FI)
Inventor: SHOENFELD YEHUDA
IPC: A61K38/00
Filed: 1996-09-12
Abstract: This invention provides therapeutic methods for inhibiting tumor metastasis and for treating primary tumors. The methods of this invention do not cause serious side effects and will be effective for a broad spectrum of cancerous diseases. In particular, the invention discloses a novel method comprising administering to a mammal a preparation of intravenous immunoglobulin (IVIG). The IVIG preparation to be administered according to this invention may contain intact immunoglobulin molecules or fragments of immunoglobulins. The preparation is administered parenterally, preferably via intravenous, intracavitary or subcutaneous routes, either as a sole agent or in combination with other agents or methods which are commonly used for cancer treatment.
Patent FI-970276-A0 (FI)
Inventor: SCHILLING DONALD L
IPC: H04B7/216
Filed: 1997-01-23
Abstract: A method for reducing interference in a direct sequence, CDMA receiver, the method comprising the steps of: a) despreading a received spread spectrum signal for each of a plurality of CDMA channels to produce a first estimate for each channel; b) for each channel, spreading the estimate obtained from the prior step for all of the other channels to produce spread other channel signals and subtracting the spread other channel signals from the received signal and despreading the subtracted result to produce a next estimate for that channel; c) repeating step b) a selected number of times; and d) combining the estimates for each channel produced by steps a), b) and c) to output a channel signal for each channel.
Patent FI-974227-A0 (FI)
Inventor: ROITTO ILKKA
IPC: B01D36/02
Filed: 1997-11-13
Abstract: The present invention relates to a method and assembly for separating foreign material from coating mix flow circulating in the machine circulation of a coating station (7) in coaters used for coating paper and board. According to the method, coating mix is conveyed from a tank (1) to a coating station, where it is applied to the surface of the web to be coated and the excess of the coating mix conveyed to the coating station (7) is returned to said tank (1). The coating mix flow incoming from said tank (1) to the coating station is screened by means of at least one pressure screen (5) and the rejects fraction of the coating mix flow is discharged from said pressure screen (5). A portion of the coating mix flow circulating in the machine circulation is passed via a vibrating screen (13) and the accepts fraction of the vibrating screen is returned back to the machine circulation. The method offers high efficiency in the removal of elongated foreign matter particles from the machine circulation of coating mix. <IMAGE>
Patent IL-59127-A0 (IL)
Title: Imidazo- and pyrimido-pyridoindoles,their preparation and pharmaceutical compositions containing them
IPC: A61P25/08
Filed: 1980-01-15
Abstract: 1. Claims for the Contracting States : BE, CH, DE, FR, GB, IT, LU, NL, SE. Imidazo and pyrimido-pyrido-indoles in form of racemates or enantiomers corresponding to formula (I)  see diagramm : EP0015786,P9,F1  wherein n is 1 or 0, R1 is a hydrogen or halogen atom, an alkyl or alkoxy radical or a CF3 group, R2 is an alkyl, cycloalkyl, cycloalkylalkyl, phenyl or benzyl radical, the two latter radicals being optionally substituted with a halogen atom or an alkyl or alkoxygroup, R3 is a hydrogen atom or an alkyl radical, R4 is a hydrogen atom or an alkyl radical, said alkyl and alkoxy radicals having 1 to 4 carbon atoms, with the exception of the compound for which n = 1, R1 = R3 = R4 = H and R2 = CH3 . 1. Claim for the Contracting State : AT A process for preparing imidazo and pyrimido-pyrido-indoles in form of racemates or enantiomers corresponding to formula (I)  see diagramm : EP0015786,P11,F3 wherein n is 1 or 0, R1 is a hydrogen or halogen atom, an alkyl or alkoxy radical or a CF3 group, R2 is an alkyl, cycloalkyl, cycloalkylalkyl, phenyl or benzyl radical, the two latter radicals being optionally substituted with a halogen atom or an alkyl or alkoxy group, R3 is a hydrogen atom or an alkyl radical, R4 is a hydrogen atom or an alkyl radical, said alkyl and alkoxy radicals having 1 to 4 carbon atoms, with the exception of the compound for which n = 1, R1 = R3 = R4 = H and R2 = CH3 , characterized in that a compound of formula (II)  see diagramm : EP0015786,P11,F4  is reacted with an amine R2 NH2 , then the intermediate compound obtained, of formula (III)  see diagramm : EP0015786,P12,F1  is cyclized by means of formaldehyde in 30% aqueous solution, and, when R4 = H, the corresponding compound (I) may be alkylated to yield a compound (I) wherein R4 is alkyl.
Patent IL-78460-A0 (IL)
Title: Heterocyclic amide derivatives,their preparation and their use as fungicides
IPC: A01N43/50
Filed: 1986-04-10
Abstract: Novel heterocyclic amide derivatives of the formula    <IMAGE>  (I) in which R1 represents alkyl, or represents alkenyl which has more than 2 carbon atoms and is optionally substituted by halogen, or represents alkinyl which has more than 2 carbon atoms and is optionally substituted by halogen, or represents alkoxyalkyl or alkylthioalkyl; R2 represents optionally substituted naphthyl, or represents optionally substituted tetrahydronaphthyl, or represents optionally substituted indanyl; A represents an alkylene bridge, or also an alkenylene bridge if X denotes a direct bond; X represents oxygen, sulphur or a direct bond; Y represents oxygen or sulphur; B represents imidazol-1-yl, pyridin-3-yl, pyrazin-2-yl, pyrimidin-5-yl, 1,2,4-triazol-1-yl or 1-methyl-imidazol-5-yl-; and their acid addition salts and metal salt complexes, are outstandingly active as fungicides.
Patent IL-81677-A0 (IL)
Title: Preparation of phenoxyalkanol-triazole compounds and intermediates therefor
IPC: C07C69/14
Filed: 1987-02-25
Abstract: Compounds of the formula <IMAGE>  in which X represents hydrogen, fluorine, chlorine, bromine, C1-C3-alkyl, C1-C3-alkoxy, trifluoromethyl, phenyl or phenoxy, m is an integer from 1 to 3, it being possible for the individual atoms or groups to be identical or different, if m is greater than 1, and n denotes an integer from 2 to 6, are prepared by reaction of alkene oxides of the formula <IMAGE> with triazole.
Patent IL-91432-A0 (IL)
Title: Optical angle measuring apparatus particularly for machine tools and the like using polygons with light reflecting facets,and method
IPC: G01D5/30
Filed: 1989-08-24
Abstract: An optical angle measuring apparatus for measuring the angular displacement of a polygon (P) with light reflecting facets (F), for use, e.g., in machine tools. The apparatus comprises projecting means (12,14,16,18) for projecting collimated light beams onto a facet (F) of a polygon, means (20) for detecting and transducing into angle measuring data the location of the focused light reflected from the polygon facets (F), means (32,34,35) for computing the difference between the angles of any given facet and an adjacent facet relative to a respective angle of an ideal regular polygon, and means (32) for processing and compensating for the said angle data to yield a corrected angle measurement. The corrected angle measurement is displayed on display means (36). A method for measuring the angular displacement of an object relative to a reference position employing the aparatus is also disclosed.
Patent IL-92165-A0 (IL)
Title: Apparatus for conducting measurements of electrochemiluminescent phenomena
IPC: H03K4/02
Filed: 1989-10-31
Abstract: An apparatus for conducting measurements of electrochemiluminescent (ECL) phenomena includes a cell unit having an electrode configuration for inducing the emission of ECL light by the application of a selected voltage waveform to a sample fluid including an ECL moiety. The sample fluid is transported to and from the cell unit by a flow-through pump/tubing system. A photomultiplier tube detects the intensity of light emitted by the sample fluid during the ECL measurement process. A computer control unit both analyzes the detected data and provides digital control signals to the cell unit to generate effective voltage waveforms. The digital control signals are supplied to a novel pulse width modulated digital to analog converter which outputs a ramp voltage waveform having the desired slope.
Patent IL-97828-A0 (IL)
Title: Substituted aromatic sulfonamides and pharmaceutical compositions containing them
IPC: C07D495/04
Filed: 1991-04-11
Abstract: Thieno[2,3-b]thiopyran-2-sulfonamides and ring homologs with a hydrophilic substituted-alkyl group adjacent to the thiopyran sulfur are carbonic anhydrase inhibitors topically effective in lowering intramocular pressure.
Patent SE-9503356-A0 (SE)
Title: Method of generating an insulation structure in a semiconductor device
Inventor: SÖDERBÄRG Anders
IPC: H01L21/786
Filed: 1995-09-28
Abstract: Abstract The present invention discloses a method of in a semiconductor device generating an insulation structure, for example a diamond material, which is being sealed from oxidizing ambients by a trench (25) into the semiconductor coating (10) and the insulator layer (20) down to the substrate layer (30), and filled with one or several layers (40, 50) acting as a barrier for oxidizing ambient present in later process steps. In another embodiment is generated a semiconductor on insulator structure for protection of the insulator, which comprises the step of introducing a barrier layer between a semiconductor layer and an insulator layer placed on an underlaying substrate layer, whereby the barrier layer protects in subsequent process steps the insulator layer from oxidizing ambient, and the semiconductor layer from contaminants resident in the insulator layer. In a further aspect the deposited barrier layers (40, 50) consists of suitable material, preferably an oxide film, deposited at a temperature so low that the insulator layer (20), for example a diamond film or a diamond like material, will not be oxidized. Fig.
Patent AU-PQ132599-A0 (AU)
Title: Nasogastric enteral formulations
IPC: A23L33/00
Filed: 1999-07-01
Abstract: The present invention relates to a nasogastric formulation comprising an amino acid source, a carbohydrate source, a lipid source, and a fatty acid delivery agent wherein the fatty acid has a bond hydrolysable in the colon to deliver free fatty acids such as short chain fatty acid acetate without having an adverse affect on the capacity to pass through a tube for tube feeding.
Patent IL-100289-A0 (IL)
Title: N-iodopropargyloxycarbonyl amino acid esters and derivatives,their preparation and their use as antimicrobial agents
IPC: C07C323/58
Filed: 1991-12-09
Abstract: Antimicrobial compounds of the formula <CHEM>  wherein R<1> is selected from the group consisting of H, lower (C1-C4)alkyl, alkyl aryl, CH2OR, CH2SR, and CH(CH3)OR; and R, R<2> and R<3> are independently selected from H, (C1-C4)alkyl, aryl, arylalkyl, alkaryl, and halopropargyl.
Patent IL-107076-A0 (IL)
Title: Process for the production of transdermal therapeutic systems and a device made by the process
IPC: A61F13/00
Filed: 1993-09-22
Abstract: PCT No. PCT/EP93/02495 Sec. 371 Date May 9, 1995 Sec. 102(e) Date May 9, 1995 PCT Filed Sep. 15, 1993 PCT Pub. No. WO94/07449 PCT Pub. Date Apr. 14, 1994The invention provides a process for the production of transdermal therapeutic systems. A layer containing active substance is initially present as a tape or web in the form of a laminate, with a carrier layer and, possibly, further auxiliary layers and/or protective layers or the like. The active substance is then transferred from this layer, either by itself or in combination with at least one further layer, in sections, to the center of a second, wider web. The process is characterized by the fact that the tape or web (1) and the second web (2) are moved forward by steps, with different phases of motion and inoperative phases and/or different step lengths and/or differing speeds and that in the same appliance, during each inoperative or stationary phase of the webs (1, 2) the subdivision of the layer containing active substance and, as the case may be, of one or more further layers, with the exception of the carrier layer, takes place in phases and in the same forward direction, at right angles to the direction of web, into sections (7, 8) containing active substance of a size suitable for the user, and their transfer to the second web, the carrier sheet (9) being removed, in preferably equal intervals, using a transfer device which can be moved backwards and forwards in the direction of the web.
Patent IL-108622-A0 (IL)
Title: New derivatives of erythromycin, their preparation process and their use as medicaments
IPC: A61P31/04
Filed: 1994-02-11
Abstract: The subject of the invention is the compounds of formula (I) <IMAGE>  in which:     - X and Y represent a hydrogen atom or together form a radical: <IMAGE>     - R represents a radical: <IMAGE> in which m represents an integer between 0 and 20, n represents a number 0, 1, 2 or 3, XA = alkyl, alkenyl, alkynyl, Hal, C IDENTICAL N, NR1R2, OR3, COR4, CO2R5, SR6, <IMAGE>  SO2R8, <IMAGE>  aryl, heteroaryl, or OC(Ar)3 and   Z = H or an acid residue.   The compounds of formula (I) have antibiotic properties.
Patent IL-113883-A0 (IL)
Title: Detergent compositions comprising oleoyl sarcosinate
IPC: C11D1/10
Filed: 1995-05-26
Abstract: Laundry detergent compositions which comprise an oleoyl sarcosinate surfactant and aluminosilicate and/or silicate builders provide cleaning benefits to fabrics in a conventional laundering operation. Thus, detergent compositions comprising various detersive ingredients, aluminosilicate and/or silicate builders, and oleoyl sarcosinate surfactant are provided.
Patent IL-117515-A0 (IL)
Title: Use of antioestrogens for controlling male fertility
IPC: A61K31/135
Filed: 1996-03-17
Abstract: This invention describes the use of antiestrogens (aromatase inhibitors, estrogen receptor antagonists) for the production of pharmaceutical agents for male birth control.
Patent IL-119207-A0 (IL)
Title: Treatment of tinnitus using neuroprotective agents
IPC: C07D451/02
Filed: 1996-09-05
Abstract: Compounds of formula I, <CHEM> and their pharmaceutically acceptable salts, wherein R<1>-R<6> are as defined herein, are useful in the treatment of tinnitus.
Patent IL-119461-A0 (IL)
Title: Pyrrolopyrimidines
IPC: C07D403/02
Filed: 1996-10-21
Abstract: The compounds of the formulawherein R1, R2, R3, R4, R5 and R6 are as defined herein, are useful in the treatment of stress-related and other diseases. These compounds have corticotropin-releasing factor antagonist activity and as such are of use in the treatment of stress and anxiety related, and other disorders.
Patent IL-122159-A0 (IL)
Title: 4-aryl-1-phenylalkyl-1,2,3,6-tetrahydropyridines their preparation and pharmaceutical compositions containing them
IPC: C07C69/65
Filed: 1996-06-26
Abstract: 4-Aryl-1-phenyl alkyl-1,2,3,6-tetrahydropyridine derivs. of formula (I), their salts, solvates and quat. ammonium salts are new. Y = CH or N; R1 = H, halo, CF3, 3-4C alkyl or 1-4C alkoxy; R2 = as R1 or OH; R3, R4 = H or 1-3C alkyl; X = 3-6C alkyl, 3-6C alkoxy, 3-7C carboxyalkyl, (1-4C) alkoxycarbonyl(3-6C)alkyl, 3-7C carboxyalkoxy or (1-4C)alkoxycarbonyl(3-6C)alkoxy; or 3-7C cycloalkyl, 3-7C cycloalkoxy, (3-7C)cycloalkylmethyl, 3-7C cycloalkylamino or cyclohexenyl (all opt. substd.); or phenyl, phenoxy, phenylamino, N-(1-3C)alkylphenylamino, phenylmethyl, phenylethyl, phenylcarbonyl, phenylthio, phenylsulphonyl, phenylsulphinyl or styryl (all opt. substd.)
Patent IL-131987-A0 (IL)
Title: Optical device for the contactless measurement of distance of a light source
IPC: G01S11/12
Filed: 1998-03-20
Abstract: The invention concerns an optical device for the contactless measurement of the distance of a light source (4) comprising optical detecting means (7) consisting of elementary sensors and further comprising: a set of N imaging means (SP1, SP2, SP3), N>=3, that enable image acquisition of the light source on a plane in the proximity of the detecting means thereby forming with said means a set of hot spots, each spot spreading over at least two elementary sensors; a circuit for computing, on the basis of the relative positions of at least three hot spots, at least one characteristic parameter of the distance from the light source whereof the accuracy depends on N number of hot spots. The measuring device is characterized in that it is designed for industrial measurements (of dimensions, texture, position, vibrations, displacement).
Patent IL-156779-A0 (IL)
Title: Purine derivatives as purinergic receptor antagonists
IPC: A61P25/04
Filed: 2002-01-10
Abstract: Use of a compound of formula (I) wherein R<SUB>1 </SUB>is selected from alkyl, aryl, alkoxy, aryloxy, 0thioalkyl, thioaryl, CN, halo, NR<SUB>5</SUB>R<SUB>6</SUB>, NR<SUB>4</SUB>COR<SUB>5</SUB>, NR<SUB>4</SUB>CONR<SUB>5</SUB>R<SUB>6</SUB>, NR<SUB>4</SUB>CO<SUB>2</SUB>R<SUB>7 </SUB>and NR<SUB>4</SUB>SO<SUB>2</SUB>R<SUB>7</SUB>; R<SUB>2 </SUB>is selected from N, O or S-containing heteroaryl groups, wherein the heteroaryl group is attached via an unsaturated carbon atom which is adjacent to one or two N, O or S-heteroatom(s), other than ortho, ortho-disubstituted heteroaryl groups; R<SUB>3 </SUB>is selected from H, alkyl, COR<SUB>8</SUB>, CONR<SUB>9</SUB>R<SUB>10</SUB>, CONR<SUB>8</SUB>NR<SUB>9</SUB>R<SUB>10</SUB>, CO<SUB>2</SUB>R<SUB>11 </SUB>and SO<SUB>2</SUB>R<SUB>11</SUB>; R<SUB>4</SUB>, R<SUB>5 </SUB>and R<SUB>6 </SUB>are independently selected from H, alkyl and aryl or where R<SUB>5 </SUB>and R<SUB>6 </SUB>are in an (NR<SUB>5</SUB>R<SUB>6</SUB>) group then R<SUB>5 </SUB>and R<SUB>6 </SUB>may be linked to form a heterocyclic ring; R<SUB>7 </SUB>is selected from alkyl and aryl; R<SUB>8</SUB>, R<SUB>9 </SUB>and R<SUB>10 </SUB>are independently selected from H, alkyl and aryl, or R<SUB>9 </SUB>and R<SUB>10 </SUB>may be linked to form a heterocyclic ring, or where R<SUB>8</SUB>, R<SUB>9 </SUB>and R<SUB>10 </SUB>are in a (CONR<SUB>8</SUB>NR<SUB>9</SUB>R<SUB>10</SUB>) group, R<SUB>8 </SUB>and R<SUB>9 </SUB>may be linked to form a heterocyclic group; and R<SUB>11</SUB>, is selected from alkyl and aryl, or a pharmaceutically acceptable salt thereof or prodrug thereof, in the treatment or prevention of a disorder in which the blocking of purine receptors, particularly adenosine receptors and more particularly A<SUB>2A </SUB>receptors, may be beneficial, particularly wherein said disorder is a movement disorder such as Parkinson's disease or said disorder is depression, cognitive or memory impairment, acute or chronic pain, ADHD or narcolepsy, or for neuroprotection in a subject; compounds of formula (I) for use in therapy; and novel compounds of formula (I) per se.
Patent IL-160563-A0 (IL)
Title: Bifunctional chelating agent for actinium
IPC: A61K49/00
Filed: 2002-09-13
Abstract: The invention concerns a ligand comprising (I) wherein n is an integer from 1 to 5 Y is CO2H or PO3H2T represents -X or -phenyl-X, wherein X represents NO2, NH2, NCS, NHCOCH2-Z, NHCO-W-COCNHS, -NH-Q, -NHCS-Q, -NHCOCH2-Q, or NHCO(CH2)m-Q where Q is a hapten chosen from the group consisting of steroids, enzymes, proteins, monoclonal antibodies, chimeric antibodies, or fragments thereof or any activated linker ready for coupling reaction, W is -(CH2)m- m is an integer from 1 to 10 Z is chloride, bromide or iodine
Patent IL-162911-A0 (IL)
Title: Bacteria with reduced genome
IPC: C12N15/09
Filed: 2003-01-22
Abstract: The present invention provides a bacterium having a genome that is genetically engineered to be at least 2 to 14% smaller than the genome of its native parent strain. A bacterium with a smaller genome can produce a commercial product more efficiently. The present invention also provides methods for deleting genes and other DNA sequences from a bacterial genome. The methods provide precise deletions and seldom introduces mutations to the genomic DNA sequences around the deletion sites. Thus, the methods can be used to generate a series of deletions in a bacterium without increasing the possibility of undesired homologous recombination within the genome. In addition, some of the methods provided by the present invention can also be used for replacing a region of a bacterial genome with a desired DNA sequence.
Patent IL-164793-A0 (IL)
Title: Methods for increasing the therapeutic response toelectroconvulsive therapy ("ect")
IPC: A61K31/56
Filed: 2003-04-28
Abstract: This invention generally pertains to the field of psychiatry. In particular, this invention pertains to the discovery that agents which inhibit the binding of cortisol to the glucocorticoid receptor can be used in methods of increasing the therapeutic response to electroconvulsive therapy ("ECT").
Patent IL-172082-A0 (IL)
Title: Foamable pharmaceutical compositions and methods for treating a disorder
IPC: A61K47/02
Filed: 2005-11-21
Abstract: Novel compositions of matter comprising a foamable delivery system are provided. Novel methods for treating a disease, disorder, or condition using the novel compositions are further provided. Novel methods for making and delivering a foamable pharmaceutical composition are also provided. While the novel compositions and foamable drug delivery system may be utilized for administration of a wide variety of drugs to epithelial tissues, to treat a wide variety of diseases, disorders, or conditions, the inventive compositions and foamable drug delivery systems are particularly useful for the dermatological administration of corticosteroids and antifungal agents.
Patent IL-176132-A0 (IL)
Title: Intranasal compositions
IPC: A61K31/435
Filed: 2006-06-05
Abstract: Compositions are provided for the intranasal administration of granisetron or a pharmaceutically acceptable salt thereof. Preferred compositions are in the form of an aqueous solution. Optionally, the compositions comprise chitosan, a salt or derivative thereof or a salt of a derivative of chitosan. The compositions can be used for the treatment or prevention of nausea and/or vomiting.
Patent IL-185763-A0 (IL)
Title: Peptides that lower blood glucose levels
IPC: C07K14/605
Filed: 2007-09-06
Abstract: The present invention relates to novel peptide conjugates which have increased stability and are useful in the treatment of excess levels of blood glucose.